165 related articles for article (PubMed ID: 12818697)
21. The involvement of histamine receptors in morphine-induced increased naloxone potency in mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):69-74. PubMed ID: 3990446
[TBL] [Abstract][Full Text] [Related]
22. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
23. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
24. The effects of pyrilamine and cimetidine on mRNA C-fos expression and nociceptive flinching behavior in rats.
Ashmawi HA; Chambergo FS; Araújo Palmeira CC; Posso IP
Anesth Analg; 2003 Aug; 97(2):541-546. PubMed ID: 12873950
[TBL] [Abstract][Full Text] [Related]
25. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
26. Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
Katsumata S; Minami M; Nakagawa T; Satoh M
Eur J Pharmacol; 1995 May; 278(2):143-50. PubMed ID: 7671998
[TBL] [Abstract][Full Text] [Related]
27. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats.
Zarrindast MR; Rostami P; Zarei M; Roohbakhsh A
Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):276-81. PubMed ID: 16236138
[TBL] [Abstract][Full Text] [Related]
28. Effects of histamine receptor antagonists on histamine-induced responses in human skin.
Hägermark O; Strandberg K; Grönneberg R
Acta Derm Venereol; 1979; 59(4):297-300. PubMed ID: 92142
[TBL] [Abstract][Full Text] [Related]
29. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Farzin D
Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
[TBL] [Abstract][Full Text] [Related]
30. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism.
Zarrindast MR; Moghimi M; Rostami P; Rezayof A
Brain Res; 2006 Sep; 1109(1):108-16. PubMed ID: 16828718
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of cimetidine/pyrilamine eyedrops. A dose response study with histamine challenge.
Leon J; Charap A; Duzman E; Shen CD
Ophthalmology; 1986 Jan; 93(1):120-3. PubMed ID: 3513080
[TBL] [Abstract][Full Text] [Related]
32. Withdrawal from repeated administration of morphine alters histamine-induced anxiogenic effects produced by intra-ventral hippocampal microinjection.
Zarrindast MR; Khodarahmi P; Rezayof A; Oryan S
J Psychopharmacol; 2010 Jun; 24(6):881-9. PubMed ID: 20093321
[TBL] [Abstract][Full Text] [Related]
33. H1- and H2-histamine receptor blockers and opiate analgesia in mice.
Leza JC; Lizasoain I; Lorenzo P
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):671-8. PubMed ID: 1983158
[TBL] [Abstract][Full Text] [Related]
34. Clonidine-induced emesis: a multitransmitter pathway concept.
Japundzić-Zigon N; Samardzić R; Beleslin DB
Pharmacol Res; 1997 Apr; 35(4):287-97. PubMed ID: 9264044
[TBL] [Abstract][Full Text] [Related]
35. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics.
Malec D
Pol J Pharmacol Pharm; 1987; 39(3):229-35. PubMed ID: 2894018
[TBL] [Abstract][Full Text] [Related]
36. Influence of intracerebroventricular administration of histaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test.
Zarrindast MR; Khalilzadeh A; Rezayat SM; Sahebgharani M; Djahanguiri B
Pharmacology; 2005 May; 74(2):106-12. PubMed ID: 15867477
[TBL] [Abstract][Full Text] [Related]
37. Comparison of peripheral and central administration of naloxone in precipitating abstinence in morphine-dependent rats.
Bell J; Adler MW
Drug Alcohol Depend; 1988 Jul; 21(3):189-94. PubMed ID: 3168761
[TBL] [Abstract][Full Text] [Related]
38. Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of α₂A-adrenoceptor.
Nakagawa T; Nagayasu K; Nishitani N; Shirakawa H; Sekiguchi K; Ikarashi Y; Kase Y; Kaneko S
Neuroscience; 2012 Dec; 227():336-49. PubMed ID: 23069764
[TBL] [Abstract][Full Text] [Related]
39. Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Ohsawa M; Kamei J
Brain Res; 1999 Jan; 815(2):424-30. PubMed ID: 9878862
[TBL] [Abstract][Full Text] [Related]
40. Involvement of central histamine receptors in corticosterone secretion induced by intraventricular administration of morphine.
Cetera B; Bugajski J; Gadek-Michalska A
Agents Actions; 1988 Apr; 23(3-4):250-3. PubMed ID: 3394572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
